A preliminary report on the effects of sustained administration of corticosteroid on traumatized disc using the adult male tat model

Journal of Spinal Disorders and Techniques

Volumn 22, Issue 7, 2009, Pages 473-478

  Ragab, Ashraf A ^a   Woodall Jr , James W ^a   Tucci, Michelle A ^a   Wingerter, Scott A ^a   Fosnaugh, Adam W ^a   Franklin, Laura N ^a   Benghuzzi, Hamed A ^b  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

Animal model; Corticosteroid; Disc degeneration; Drug delivery; Surgical technique; Sustained release; Tricalcium phosphate ceramic

Indexed keywords

CALCIUM PHOSPHATE CERAMIC; CORTICOSTERONE; LYSINE; TOBRAMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARTILAGE CELL; CELL COUNT; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG DELIVERY SYSTEM; DRUG EFFECT; EXPERIMENTAL MODEL; INFLAMMATION; INTERVERTEBRAL DISK DEGENERATION; LUMBAR DISK; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPINE INJURY; SUSTAINED DRUG RELEASE; TREATMENT OUTCOME;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BIOCOMPATIBLE MATERIALS; CALCIUM PHOSPHATES; CELL COUNT; CHONDROCYTES; CORTICOSTERONE; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; FIBROCARTILAGE; INFLAMMATION; INTERVERTEBRAL DISK; INTERVERTEBRAL DISK DEGENERATION; MALE; RATS; RATS, SPRAGUE-DAWLEY; REGENERATION; TREATMENT OUTCOME;

EID: 70349852461     PISSN: 15360652     EISSN: None     Source Type: Journal    
DOI: 10.1097/BSD.0b013e31818d5e55     Document Type: Article

References (14)

1. Andersson GB. Epidemiological features of chronic low-back pain. Lancet. 1999;354:581-585.
2. Miller JA, Schmatz C, Schultz AB. Lumbar disc degeneration: correlation with age, sex, and spine level in 600 autopsy specimens. Spine. 1988;13:173-178.
3. Walsh AJ, Bradford DS, Lotz JC. In vivo growth factor treatment of degenerated intervertebral discs. Spine. 2004;29:156-163.
4. Kroeber MW, Unglaub F, Wang H, et al. New in vivo animal model to create intervertebral disc degeneration and to investigate the e.ects of therapeutic strategies to stimulate disc regeneration. Spine. 2002;27:2684-2690.
5. Sobajima S, Kompel JF, Kim JS, et al. A slowly progressive and reproducible animal model of intervertebral disc degeneration characterized by MRI, X-ray, and histology. Spine. 2005;30:15-24.
6. Masuda K, Aota Y, Muehleman C, et al. A novel rabbit model of mild, reproducible disc degeneration by an annulus needle puncture: correlation between the degree of disc injury and radiological and histological appearances of disc degeneration. Spine. 2005;30:5-14.
7. Jager M, Sager M, Lensing-Hohn S, et al. The critical size bony defect in a small animal for bone healing studies (I): comparative anatomical study on rats' femur. Biomed Tech (Berl). 2005;50: 107-110.
8. Lipson SJ, Muir H. 1980 Volvo award in basic science. Proteoglycans in experimental intervertebral disc degeneration. Spine. 1981;6:194-210.
9. Singh K, Masuda K, An HS. Animal models for human disc degeneration. Spine J. 2005;5:267S-279S.
10. Benghuzzi HA, Barbaro RM, Bajpai PK. Sustained delivery of 3Hthymidine by means of ceramic capsules in rats. Biomed Sci Instrum. 1989;25:169-177.
11. Graham JT, Win.eld A, Tucci M, et al. The e.ects of sustained delivery of glucocorticoids on the adrenal gland of male rats. Biomed Sci Instrum. 2003;39:347-352. (Pubitemid 36433451)
12. Matsumoto M, Chosa E, Nabeshima K, et al. In.uence of bioresorbable, unsintered hydroxyapatite/poly-L-lactide composite .lms on spinal cord, nerve roots, and epidural space. J Biomed Mater Res. 2002;60:101-109.
13. Takegami K, Thonar EJ, An HS, et al. Osteogenic protein-1 enhances matrix replenishment by intervertebral disc cells previously exposed to interleukin-1. Spine. 2002;27:1318-1325.
14. Thompson JP, Oegema TR Jr, Bradford DS. Stimulation of mature canine intervertebral disc by growth factors. Spine. 1991;16: 253-260.